Vimarsana
Biggest News Aggregation in the World

Page 2 - Breaking Abstract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breaking Abstract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breaking Abstract Today - Breaking & Trending Today

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR) - Vimarsana News

Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR)

- Arrowhead Expands the Reach of RNAi Therapies to Address Diseases in the Lung - Late-Breaking Clinical Data for ARO-RAGE for Treatment of Asthma Demonstrate Deep and Durable Gene Silencing - Promising Preclinical

Blood Pressure–Lowering After Thrombectomy May Be Harmful - Vimarsana News

Blood Pressure–Lowering After Thrombectomy May Be Harmful

Preliminary results of a new study showed that using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg in these patients may not be beneficial, and may even be harmful.

Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 37th Annual Meeting - Vimarsana News

Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 37th Annual Meeting

Milwaukee, WI (PRWEB) November 02, 2022 -- The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2022,

Source: prweb.com
Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn - Vimarsana News

Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn

GOTHENBURG, Sweden, Aug. 19, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a...

Vicore Pharma Holding AB: Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn - Vimarsana News

Vicore Pharma Holding AB: Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn

GOTHENBURG, Sweden, Aug. 19, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2